Device Trial Radar · NCT02417441
TiLE (Time Lapse Eeva) Clinical Trial
Last checked: Nov 19, 2026Latest source record: Jan 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
976
Actual
Start
Jun 29, 2015
Primary completion
Feb 9, 2017
Study completion Feb 9, 2017
Sponsor
- Lead sponsor
- Merck KGaA, Darmstadt, GermanyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 15, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- Who can join
- Female only, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study was to explore the added value of adjunctive use of Early Embryo Viability Assessment (Eeva) with morphological grading in identifying optimal embryos for transfer.
Conditions
- Fertility
Interventions
EevaDevice
Embryos of subjects randomized in this group were assessed using Eeva System and morphological grading to identify optimal embryos for transfer.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Implantation RateTime frame: Gestational Weeks 5 to 8
Locations
23 sites in 9 countries. Site status is shown where the registry gives one.
Mount Sinai Hospital
Toronto, Canada
Cambrian Wellness Centre
Calgary, Alberta, Canada
One Fertility
Burlington, Ontario, Canada
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.